Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

Mingchuang Zhu,Qingpeng Zeng,Tao Fan,Yuanyuan Lei,Feng Wang,Sufei Zheng,Xinfeng Wang,Hui Zeng,Fengwei Tan,Nan Sun,Qi Xue,Jie He

DOI: https://doi.org/10.3389/fimmu.2022.909105

IF: 7.3

2022-05-04

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.783495.].

immunology

What problem does this paper attempt to address?

Corrigendum: Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis

Wei Zhang,Weiwei Wang,Junlu Wu,Jiale Tian,Wenhui Yan,Yi Yuan,Yiwen Yao,Anquan Shang,Wenqiang Quan

DOI: https://doi.org/10.3389/fonc.2022.1118042

2022-12-15

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.942964.].
Corrigendum: Lipid metabolism and tumor immunotherapy

Yue Wang,Zongjin Guo,Adamu Danbala Isah,Shuangwei Chen,Yongfei Ren,Huazhong Cai

DOI: https://doi.org/10.3389/fcell.2024.1349379

IF: 5.5

2024-01-26

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2023.1187989.].

cell biology,developmental biology
Corrigendum to “Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis”

Bi-Cheng Wang,Bo-Ya Xiao,Peng-Cheng Li,Bo-Hua Kuang,Wang-Bing Chen,Pin-Dong Li,Guo-He Lin,Quentin Liu

DOI: https://doi.org/10.1155/2021/3735726

IF: 4.501

2021-02-25

Journal of Oncology

Abstract:[This corrects the article DOI: 10.1155/2020/2368164.].

oncology
Corrigendum: Tumor-Associated Macrophages in Tumor Immunity

Yueyun Pan,Yinda Yu,Xiaojian Wang,Ting Zhang

DOI: https://doi.org/10.3389/fimmu.2021.775758

IF: 7.3

2021-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2020.583084.].
Corrigendum: Immunogenomic landscape in breast cancer reveals immunotherapeutically relevant gene signatures

Tao Wang,Tianye Li,Baiqing Li,Jiahui Zhao,Zhi Li,Mingyi Sun,Yan Li,Yanjiao Zhao,Shidi Zhao,Weiguang He,Xiao Guo,Rongjing Ge,Lian Wang,Dushan Ding,Saisai Liu,Simin Min,Xiaonan Zhang

DOI: https://doi.org/10.3389/fimmu.2023.1134847

IF: 7.3

2023-01-20

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.805184.].

immunology
Corrigendum: Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma

Yaxin Chen,Lei Xia,Yuxuan Peng,Gang Wang,Liyun Bi,Xue Xiao,Cui Li,Weimin Li

DOI: https://doi.org/10.3389/fonc.2023.1309950

IF: 4.7

2023-11-07

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.947808.].

oncology
Corrigendum: Identification of Microtube-Associated Biomarkers in Diffuse Large B-cell Lymphoma and Prognosis Prediction.

Wenqi Wu,Su Liu,Linyan Tian,Cheng Li,Yanan Jiang,Jinhuan Wang,Yangyang Lv,Jing Guo,Donghui Xing,Yixin Zhai,Huimeng Sun,Yuhang Li,Luying Zhang,Xiang He,Kaiping Luo,Hongjie Zhan,Zhigang Zhao

DOI: https://doi.org/10.3389/fgene.2023.1180076

IF: 3.7

2023-01-01

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.1092678.].
Corrigendum: The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma

Wan He,Gengpeng Lin,Chaohu Pan,Wenwen Li,Jing Shen,Yangli Liu,Hui Li,Dongfang Wu,Xuejia Lin

DOI: https://doi.org/10.3389/fgene.2022.879922

IF: 3.7

2022-03-11

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.761681.].

genetics & heredity
Corrigendum: Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer

Anli Yang,Ying Zhou,Yanan Kong,Xiaoli Wei,Feng Ye,Lijuan Zhang,Xian Zhong,Mingyue Li,Shilin Lu,Xin An,Weikai Xiao

DOI: https://doi.org/10.3389/fimmu.2024.1372991

IF: 7.3

2024-01-31

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.704557.].

immunology
Corrigendum: Dissecting the single-cell transcriptome network of immune environment underlying cervical premalignant lesion, cervical cancer and metastatic lymph nodes

Chunbo Li,Keqin Hua

DOI: https://doi.org/10.3389/fimmu.2024.1386072

IF: 7.3

2024-02-23

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.897366.].

immunology
Corrigendum: the Significance of Transarterial Chemo(embolization) Combined with Tyrosine Kinase Inhibitors and Immune Check Point Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review

Qiao Ke,Fuli Xin,Huipeng Fang,Yongyi Zeng,Lei Wang,Jingfeng Liu

DOI: https://doi.org/10.3389/fimmu.2022.952446

IF: 7.3

2022-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.913464.].
Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis

Xu-Sheng Liu,Lu-Meng Zhou,Ling-Ling Yuan,Yan Gao,Xue-Yan Kui,Xiao-Yu Liu,Zhi-Jun Pei

DOI: https://doi.org/10.3389/fimmu.2021.751004

IF: 7.3

2021-08-31

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.724741.].

immunology
Corrigendum: Lipid metabolism in tumor immunology and immunotherapy

Lisa K. Duong,Halil Ibrahim Corbali,Thomas S. Riad,Shonik Ganjoo,Selene Nanez,Tiffany Voss,Hampartsoum B. Barsoumian,James Welsh,Maria Angelica Cortez

DOI: https://doi.org/10.3389/fonc.2023.1358498

IF: 4.7

2024-01-08

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1187279.].

oncology
Corrigendum: T lymphocyte cell: A pivotal player in lung cancer

Yanan Wu,Meng Yuan,Chenlin Wang,Yanfei Chen,Yan Zhang,Jiandong Zhang

DOI: https://doi.org/10.3389/fimmu.2023.1166352

IF: 7.3

2023-02-21

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1102778.].

immunology
Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis

Xiaoyu Zhang,Xiaoqin He,Yue Li,Yangtao Xu,Wenliang Chen,Xin Liu,Xinyao Hu,Lin Xiong,Ximing Xu

DOI: https://doi.org/10.3389/fmolb.2021.826905

IF: 6.113

2021-12-22

Frontiers in Molecular Biosciences

Abstract:[This corrects the article DOI: 10.3389/fmolb.2021.702206.].

biochemistry & molecular biology
Corrigendum: Neoadjuvant Tislelizumab Combined with Chemotherapy in Locally Advanced Oral or Oropharyngeal Squamous Cell Carcinoma: a Real-World Retrospective Study.

Wen-Jie Wu,Qian Liu,Pu-Gen An,Lin Wang,Jian-Yun Zhang,Yan Chen,Tong Zhang,Jie Zhang

DOI: https://doi.org/10.3389/fimmu.2023.1346845

IF: 7.3

2024-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1282629.].
Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies

Jun Cao,Mengdi Zhang,Bin Wang,Long Zhang,Fangfang Zhou,Meiyu Fang

DOI: https://doi.org/10.3389/fonc.2021.745052

IF: 4.7

2021-08-17

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.658552.].

oncology
Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma

Tingting Deng,Yang Liu,Jialang Zhuang,Yizhe Tang,Qin Huo

DOI: https://doi.org/10.3389/fonc.2022.979968

IF: 4.7

2022-08-22

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.632042.].

oncology
Corrigendum: Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

Haiyang Zhao,Kexin Luo,Meihan Liu,Yuanze Cai,Siman Liu,Shijuan Li,Yongsheng Zhao,Hongpan Zhang

DOI: https://doi.org/10.3389/fgene.2024.1531321

IF: 3.7

2024-12-04

Frontiers in Genetics

Abstract:This article is a correction to: Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

genetics & heredity
Corrigendum: Antigen Presentation Machinery Signature-Derived CALR Mediates Migration, Polarization of Macrophages in Glioma and Predicts Immunotherapy Response

Rui Chen,Hao Zhang,Wantao Wu,Shuyu Li,Zeyu Wang,Ziyu Dai,Zaoqu Liu,Jian Zhang,Peng Luo,Zhiwei Xia,Quan Cheng

DOI: https://doi.org/10.3389/fimmu.2022.931433

IF: 7.3

2022-06-02

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.833792.].

immunology

Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

Corrigendum: Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis

Corrigendum: Lipid metabolism and tumor immunotherapy

Corrigendum to “Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis”

Corrigendum: Tumor-Associated Macrophages in Tumor Immunity

Corrigendum: Immunogenomic landscape in breast cancer reveals immunotherapeutically relevant gene signatures

Corrigendum: Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma

Corrigendum: Identification of Microtube-Associated Biomarkers in Diffuse Large B-cell Lymphoma and Prognosis Prediction.

Corrigendum: The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma

Corrigendum: Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer

Corrigendum: Dissecting the single-cell transcriptome network of immune environment underlying cervical premalignant lesion, cervical cancer and metastatic lymph nodes

Corrigendum: the Significance of Transarterial Chemo(embolization) Combined with Tyrosine Kinase Inhibitors and Immune Check Point Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review

Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis

Corrigendum: Lipid metabolism in tumor immunology and immunotherapy

Corrigendum: T lymphocyte cell: A pivotal player in lung cancer

Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis

Corrigendum: Neoadjuvant Tislelizumab Combined with Chemotherapy in Locally Advanced Oral or Oropharyngeal Squamous Cell Carcinoma: a Real-World Retrospective Study.

Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies

Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma

Corrigendum: Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

Corrigendum: Antigen Presentation Machinery Signature-Derived CALR Mediates Migration, Polarization of Macrophages in Glioma and Predicts Immunotherapy Response